LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

Home・Aandelen Lijst・Schrodinger Inc

Schrodinger Inc

Open

SectorGezondheidszorg

12.89 -1.53

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

12.87

Max

13.35

Belangrijke statistieken
By Trading Economics
Inkomsten	169M 136M
Verkoop	33M 87M
EPS	-0.18
Winstmarge	155.644
Werknemers	850
EBITDA	67M 36M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+46.61% upside

Dividenden
By Dow Jones
Volgende Winsten	5 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	137M 964M
Vorige openingsprijs	14.42
Vorige sluitingsprijs	12.89

Nieuwssentiment

By Acuity

72%

28%

315 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

23.27 / 26.13 Steun & Weerstand

Schrodinger Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 mei 2026, 23:47 UTC

Marktinformatie

Gold Falls on Renewed Inflation Concerns -- Market Talk

10 mei 2026, 23:44 UTC

Marktinformatie

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

10 mei 2026, 23:38 UTC

Marktinformatie

Oil Rises Amid Signs of Ongoing Middle East Tensions -- Market Talk

10 mei 2026, 23:14 UTC

Marktinformatie

Australia's Political Map Continues to Be Redrawn -- Market Talk

10 mei 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Elevra Lithium: Expects Deal to Close in 1Q FY27

10 mei 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Elevra Lithium: Expects to Received About $71 Million Before Fees, Taxes in Cash

10 mei 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Elevra Lithium Agrees to Sell Ewoyaa Lithium Project Stake to Zhejiang Huayou Cobalt

10 mei 2026, 10:21 UTC

Winsten

Saudi Aramco Profit Jumps Despite War Disrupting Shipping Routes -- WSJ

9 mei 2026, 06:05 UTC

Winsten

Our Innodata Stock Pick Smashed Earnings Expectations. Stay Long. -- Barrons.com

8 mei 2026, 23:55 UTC

Winsten

Review & Preview: Still Going Strong -- Barrons.com

8 mei 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 mei 2026, 20:49 UTC

Winsten

Why the Gap Between Chip and Software Stocks Keeps Getting Wider -- Barrons.com

8 mei 2026, 20:25 UTC

Winsten

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8 mei 2026, 19:43 UTC

Winsten

Cencosud 1Q Rev $4.565B >CENCOSUD.SN

8 mei 2026, 19:43 UTC

Winsten

Cencosud 1Q Net $115M

8 mei 2026, 19:20 UTC

Marktinformatie

Oil Futures End Session Higher, But Down on the Week -- Market Talk

8 mei 2026, 19:18 UTC

Winsten

Monster and Celsius Earnings Show Energy-Drink Fatigue Is Far From Over -- Barrons.com

8 mei 2026, 19:16 UTC

Winsten

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8 mei 2026, 19:08 UTC

Winsten

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8 mei 2026, 19:05 UTC

Winsten

Investors Feared Energy-Drink Fatigue. Monster and Celsius Earnings Offered Reassurance. -- Barrons.com

8 mei 2026, 19:02 UTC

Marktinformatie

U.S. Natural Gas Futures Little Changed on Week -- Market Talk

8 mei 2026, 18:51 UTC

Winsten

Memory Stocks Continue to Surge. What's Driving Micron and Sandisk Higher. -- Barrons.com

8 mei 2026, 18:49 UTC

Winsten

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8 mei 2026, 18:41 UTC

Winsten

McDonald's Stock Rises on Earnings Beat. The Value Push Needs to Maintain Momentum. -- Barrons.com

8 mei 2026, 17:38 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 2 to 410 -- Market Talk

8 mei 2026, 17:14 UTC

Winsten

How High Gas Prices Need to Rise to Boost Electric Vehicle Sales -- Barrons.com

8 mei 2026, 17:04 UTC

Marktinformatie

Zcash Caps Off Parabolic Week -- Market Talk

8 mei 2026, 16:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

8 mei 2026, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 mei 2026, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Schrodinger Inc Prognose

Koersdoel

By TipRanks

46.61% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 19.25 USD 46.61%

Hoogste 24 USD

Laagste 13 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Schrodinger Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Schrodinger Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

23.27 / 26.13Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

315 / 347 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.